Emerging roles of epithelial-mesenchymal transition in hematological malignancies

San Chi Chen, Tsai Tsen Liao, Muh Hwa Yang*

*此作品的通信作者

研究成果: Review article同行評審

44 引文 斯高帕斯(Scopus)

摘要

Background: Epithelial-mesenchymal transition is an important process in embryonic development, fibrosis, and cancer metastasis. During the progression of epithelial cancer, activation of epithelial-mesenchymal transition is tightly associated with metastasis, stemness and drug resistance. However, the role of epithelial-mesenchymal transition in non-epithelial cancer is relatively unclear. Main body: Epithelial-mesenchymal transition transcription factors are critical in both myeloid and lymphoid development. Growing evidence indicates their roles in cancer cells to promote leukemia and lymphoma progression. The expression of epithelial-mesenchymal transition transcription factors can cause the differentiation of indolent type to the aggressive type of lymphoma. Their up-regulation confers cancer cells resistant to chemotherapy, tyrosine kinase inhibitors, and radiotherapy. Conversely, the down-regulation of epithelial-mesenchymal transition transcription factors, monoclonal antibodies, induce lymphoma cells apoptosis. Conclusions: Epithelial-mesenchymal transition transcription factors are potentially important prognostic or predictive factors and treatment targets for leukemia and lymphoma.

原文English
文章編號37
期刊Journal of Biomedical Science
25
發行號1
DOIs
出版狀態Published - 23 4月 2018

指紋

深入研究「Emerging roles of epithelial-mesenchymal transition in hematological malignancies」主題。共同形成了獨特的指紋。

引用此